No Detail Found!

Challenges in Treating Pediatric Neuroblastoma at The Children’s Hospital and Institute of Child Health, Lahore

Author(s)
Safwan Ahmed Department of Pediatric Hematology Oncology, University of Child Health Science, Children’s Hospital, Lahore, Pakistan
Mohammad Shafiq Department of Pediatric Hematology Oncology, University of Child Health Science, Children’s Hospital, Lahore, Pakistan
Mahwish Faizan Department of Pediatric Hematology Oncology, University of Child Health Science, Children’s Hospital, Lahore, Pakistan
Huma Zafar Department of Pediatric Hematology Oncology, University of Child Health Science, Children’s Hospital, Lahore, Pakistan
Shazia Riaz Department of Pediatric Hematology Oncology, University of Child Health Science, Children’s Hospital, Lahore, Pakistan
Sadia Anwar Department of Pediatric Hematology Oncology, University of Child Health Science, Children’s Hospital, Lahore, Pakistan
Abstract
Objective: To demonstrate challenges in treating pediatric neuroblastoma at The Children’s Hospital and Institute of Child Health, Lahore. Study Design: Descriptive observational study Place and Duration of Study: The study was conducted in Pediatric Hematology Oncology Department, The Children’s Hospital and Institute of Child Health, Lahore in twelve months from March 2020 to February 2021. Material and Methods: Study was conducted on total of 60 patients of diagnosed neuroblastoma. Main variables of study were age, parents education, socioeconomic status, traveling distance, Life threatening symptoms (LTS), and International neuroblastoma staging system (INSS) stage. SPSS version 23.1 was used for data analysis. Test of significance was applied taking p value =0.05 as significant value. Results: Regarding histopathology, fifty eight (96%) patients had neuroblastoma while 4% patients had ganglioneuroblastoma. Life threatening symptoms were present in 85% patients. Most common primary sites were suprarenal 45%, retroperitoneum 25%, pre/paravertebral 11%, posterior mediastinal 11%, others 6%. Metastasis were present in 40% patients at diagnosis and most common metastatic sites were bone marrow 21%, bone 8% and both 10%. Conclusion: Advanced disease presentation is common, high-risk neuroblastoma is considered challenging and has one of the least favorable outcomes amongest cancers. Late diagnosis due to cultural and socioeconomic barriers and lack of care at primary care level and poor referral to oncology units owing to deficient health care system are the major contributory challenges for management and poor outcomes.
Publication Details
Page(s) 392-397
DOI DOI not available
Published Journal: Pakistan Paediatric Journal, Volume: 46, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
Management, Challenges, Children, Neuroblastoma
0

Citations

0

Downloads

52

Views